Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-Cd38 Cytolytic Antibody TAK-079 in Healthy Subjects

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.14241

Related search